Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SiCortex was a high-performance computing (HPC) company that developed energy-efficient supercomputers specifically designed for data-intensive applications, including bioinformatics, genomic sequencing, and protein modeling. Founded in 2003 and backed by prominent venture capital firms like Flagship Pioneering and Polaris Venture Partners, the company aimed to provide massive computational power with a fraction of the energy consumption of traditional clusters. Despite its innovative architecture based on MIPS processors, SiCortex ceased operations in 2009 due to financial challenges during the economic downturn. Its technology was primarily utilized by research institutions and biotechnology firms for complex biological simulations and large-scale data analysis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SiCortex.